Experts of IPB University Discussed about COVID-19 from Many Perspectives

Rector of IPB University, Prof. Dr. Arif Satria, said that people must have a growth mindset during a pandemic period, so that we could easily adapt and find new ways to face the problems. That point was delivered in the Webinar "The University's Existence in Supporting The Actual and Rational Covid-19 Diagnosis and Therapy", (8/10). The webinar, which was held by IPB University lecturers who are the members of Prajab 05, presented The Crisis Center Team of IPB University to provide an explanation regarding the handling of COVID-19 in campus.

The Crisis Center Team Leader, Prof Dr Dodik Ridho Nurrochmat, said that the handling of COVID-19 at IPB University was carried out according to regulation, starting from treatment at the Polyclinic of IPB University to hospital referral.

Meanwhile, in that opportunity, dr Darwati from the Polyclinic at Vocational School of IPB University, said that the diagnosis of COVID-19 must be carried out comprehensively because the symptoms are not specific, only attacking the upper respiratory tract. Sometimes patients who come either show symptoms like diarrhea and enervate or show no symptoms at all. Thus, it is necessary to have an appropriate analysis so that the patient's status could be determined and handled without false screening or false examination results.

"Comprehensive examination, besides PCR test which sometimes could be mistaken, is also needed to diagnose COVID-19, starting from laboratory tests to radiology. Rapid test is not a reference for diagnosis, but rather for the purpose of research or epidemiology," she said.

For the purpose of sample testing, Dr drh Huda S Darusman, a lecturer of IPB University from the Faculty of Veterinary Medicine and also The Head of Primate Research Center (PSSP), Institute of Research and Community Service (LPPM) IPB University, said that laboratories of IPB University had received 4000 (samples) and all reported in under 48 hours. 

"In developing the facility and management of a university-scale COVID-19 testing laboratory, it must be started based on documentation and cross checking the standard operating procedures (SOP). Sample storage information must also be thoroughly known. IPB University is the only university which has a permit as a reference laboratory, "he added.

Meanwhile, Dr drh Okti N Poetri from the Faculty of Veterinary Medicine, IPB University, explained that viral culture is the most appropriate method of diagnostic testing, but that method is difficult to do because of the dangerous nature of COVID-19.

She also showed that the body will start to produce antibodies after seven days of exposure so that self-isolation for 15 days is the best step to prevent further transmission.

"PCR tests which were carried out on the first day to the seventh day will show positive results while rapid tests will show negative results (not reactive) because antibodies or immunoglobulin-G have not been formed. So that is many situation could be happened, the PCR was positive while the rapid was negative, the PCR was positive and the rapid also positive or the PCR was negative while the rapid was positive, that depends on the chronology," she explained.

As a prevention from the exposure of COVID-19 and increasing endurance, Prof Dr Irmanida Batubara from the Department of Chemistry, Faculty of Mathematics and Natural Sciences (FMIPA) who is also the Head of the Tropical Biopharmaca Research Center, LPPM IPB University, said that based on Ristoja, Indonesia has a lot of natural ingredients which are able to produce nutritious secondary metabolites for body fitness.

Through a series of research, natural ingredients or jamu might be used as therapy for COVID-19 patients. For example, guava has been used as an antiviral on 305 formulas. Followed by turmeric, bamboo, coconut, etc. which are considered to reduce comorbid effects.

Subsequent research will be focused on guava leaf which has better effectiveness than other plant parts based on the predictive model for potential antiviral from SARS-Cov2 using ligand and structure-based pharmacomodeling. The results showed that guava leaf extract could inhibit viral replication based on the interaction of the metabolite compounds. However, for now, further pharmacodynamic research will be started, but clinical research is still beyond the reach. (IAAS/ISL)



Published Date : 08-Oct-2020

Resource Person : Prof Dr Arif Satria

Keyword : Crisis Center Team of IPB University, COVID-19, lecturer of IPB